A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation
PHASE3
The purpose of this study was to determine the clinical benefit of ASP2215 ...
A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)
PHASE3
The main objective of this study is to evaluate the efficacy of venetoclax ...
Status
Terminated
Location
Arizona Oncology - Scottsdale - Cancer Transplant Institute /ID# 239711
Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System (IPSS) Low-risk and Intermediate-1 Myelodysplastic Syndrome (MDS) Patients, Resistant to Erythropoetin-stimulating Agents (ESA)
PHASE2
The study is aimed to treat low-risk MDS patients,who are dependent on red-...